Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACOR - Acorda Q4 Ampyra sales down 60% on generic encroachment

ACOR - Acorda Q4 Ampyra sales down 60% on generic encroachment

Acorda Therapeutics Inc.
  • Acorda Therapeutics (ACOR) Q1 results: Revenues: $44.1M (-58.5%); Ampyra sales: $41.3M (-59.9%); Royalty revenues: $2.8M (-12.5%); Inbrija sales: $1.3M.
  • More news on: Acorda Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary,
    • Read more ...
Stock Information
Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com
Menu
ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...